IP Library Granted Patent US 10,143,778
Granted Patent B2
US 10,143,778 · App. 15/386,640 · Granted Dec 4, 2018

Cardiovascular prostheses

Inventor: Robert G Matheny (Norcross, GA)
Assignee: CORMATRIX CARDIOVASCULAR, INC
A61L27/3633A61F2/0095A61F2/06A61K31/4418A61L27/34A61L27/3834A61L27/507A61L27/54A61L27/58A61F2210/0004A61F2250/0067A61L2300/414A61L2430/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,778
App. No.
15/386,640
Granted
Dec 4, 2018
Kind
B2
Abstract

Cardiovascular prostheses for treating, reconstructing and replacing damaged or diseased cardiovascular tissue that are formed from acellular extracellular matrix (ECM). The cardiovascular prostheses comprise various compositions, such as ECM based compositions, and structures, such as particulate structures, mesh constructs, encasement structures, coated structures and multi-sheet laminate structures.

Claims (5)

1. A vascular graft for treating damaged or diseased tissue, comprising:

a sheet member comprising top and bottom surfaces, and an outer coating layer disposed on said sheet member top surface, said outer coating layer comprising poly(glycerol sebacate) (PGS),

said sheet member consisting of an exosome augmented composition consisting of acellular ECM derived from mammalian tissue source selected from the group consisting of small intestine submucosa (SIS), mesothelial tissue, placental tissue and cardiac tissue and a plurality of exogenous exosomes derived from mesenchymal stem cells (MSCs),

said sheet member, when disposed proximate damaged tissue, being adapted to reduce an inflammatory phase of said damaged tissue and, thereby, reduce an inflammatory response thereof, whereby said sheet member induces enhanced, stem cell proliferation, neovascularization, remodeling of said damaged tissue, and regeneration of new tissue and tissue structures with site specific structural and functional properties, compared to induced stem cell proliferation, neovascularization, remodeling, and regeneration of new tissue and tissue structures by an ECM sheet member consisting solely of acellular mammalian ECM,

said coated top surface of said sheet member, when disposed proximate said damaged tissue, being adapted to adhere to said damaged tissue, degrade and exhibit a linear degradation profile.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2025
From: CORMATRIX CARDIOVASCULAR, INC.
To: CORVIVO CARDIOVASCULAR, INC.
Reel/Frame 070482/0001 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO MED, LLC
To: ELUTIA MED LLC
Reel/Frame 064923/0704 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO BIOLOGICS, INC.
To: ELUTIA INC.
Reel/Frame 064923/0361 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061164/0532 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061161/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2021
From: AZIYO MED, LLC
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 055941/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: CORMATRIX CARDIOVASCULAR, INC.
To: AZIYO MED, LLC
Reel/Frame 042577/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2016
From: MATHENY, ROBERT G
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 040745/0830 →
Continuity (3)
Continuation In Part 13328287 · Dec 16, 2011
Provisional Application 61425287 · Dec 21, 2010
Related Publication 20170100515A1 · Apr 13, 2017
Cited By (1)
US 12,514,958